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A study to investigate the ability of subjects with
chronic lung diseases to provide evidential breath
samples using the Lion Intoxilyzer1 6000 UK breath
alcohol testing device
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*Department of Respiratory Medicine, Birmingham Heartlands Hospital, Birmingham B9 5SS, U.K.
The Lion Intoximeter1 3000 has been used for evidential breath testing in the U.K. for some years. Some
individuals with lung diseases have diculty in providing evidential breath samples using the device. This study
describes an investigation that we have carried out on a newer instrument — the Lion Intoxilyzer1 6000UK —
which is now in use in the U.K. The study was designed to investigate the ability of subjects with a variety of lung
diseases to provide evidential breath samples using this device. The 40 adult subjects investigated comprized 10
normal controls, 10 with asthma, 10 with chronic obstructive pulmonary disease (COPD) and 10 with restrictive
lung disease. After baseline spirometry, subjects were given alcohol to drink, the quantity based upon body weight.
After a gap of at least 20 min, subjects were asked to provide evidential breath samples in accordance with the test
procedure built into the Lion Intoxilyzer 6000UK. The results showed that two asthmatic subjects, four with
COPD and three with restrictive lung disease failed to provide evidential breath samples even after four attempts.
Despite the device requiring a minimum sample volume of 12 l, eight of the nine subjects who failed had a forced
vital capacity (FVC) of more than 15 l. Seven of these nine subjects had a forced expiratory volume in 1 sec (FEV1)
of less than 10 l. In conclusion, this study has shown that some subjects with lung diseases may have diculty in
providing evidential breath samples using the Lion Intoxilyzer 6000 UK.
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Police in the U.K. currently use a screening device for
roadside breath alcohol testing. If a roadside screening test
proves positive or if the subject is unable to activate the
device, he or she is arrested and taken to the Police Station
to provide an evidential breath sample. The Lion Intoxi-
meter1 3000 has been in use in police stations for evidential
breath testing for many years. Some individuals with lung
diseases have diculty in providing evidential breath
samples using the device (1). We have looked at a newer
instrument, the Lion Intoxilyzer1 6000UK, in order to
assess whether subjects with a respiratory disease have
diculty in providing evidential breath samples using the
device. Chest Physicians are frequently asked to give an
opinion as to whether a subject with lung disease may have
been unable to provide evidential breath samples because ofReceived 5 November 1999 and accepted in revised form 12
January 2000.
Correspondence should be addressed to: Dr D. Honeybourne,
Department of Respiratory Medicine, Birmingham Heartlands
Hospital, Bordesley Green East, Birmingham B9 5SS, U.K.
0954-6111/00/070684+05 $35?00/0impaired lung function. The aim of this study was to
investigate whether one or more spirometric parameters
could indicate which subjects would be unable to provide
evidential breath samples using the Lion Intoxilyzer 6000
UK. A previous study looking at the Lion Alcolmeter1
SL2 (a roadside testing device) found that subjects with a
forced expiratory volume in 1 sec (FEV1) of less than 15 l
or a FEV1 of less than 50% of predicted value were unlikely
to be able to activate the device (2). A later study looking at
the Lion Alcolmeter SL-400 (a newer roadside testing
device) found that subjects who had a FEV1 of less than 11
l were unlikely to be able to activate the device (3).
Methods
SUBJECTS
The subjects studied consisted of 10 adult controls who had
no evidence of underlying lung disease, 10 subjects with
chronic obstructive pulmonary disease (COPD), 10 with
asthma and 10 with restrictive lung disease. The subjects
with lung disease were recruited from patients at the City# 2000 HARCOURT PUBLISHERS LTD
CHRONIC LUNG DISEASE AND THE LION INTOXILYZER1 685Hospital, Dudley Road, Birmingham, U.K. All subjects
gave written informed consent and the study received
approval from the Hospital Ethics Committee.
For the purposes of the study, subjects with COPD were
those who had a FEV1 less than 50% of predicted value and
the criteria for diagnosis were as recommended by the
British Thoracic Society (4). Subjects with asthma were
those who had a forced expiratory ratio (FER or FEV1/
FVC) less than 60% and at least 15% reversibility in FEV1
after a bronchodilator. Those with restrictive lung disease
had a forced vital capacity (FVC) less than 25 l and
FER70%. All of the subjects with lung disease also had a
clinical diagnosis and history consistent with the respective
disease category.
RESPIRATORY FUNCTION TESTING
Subjects were invited to attend in the early afternoons.
Spirometry was performed strictly in accordance with
British Thoracic Society/Association of Respiratory
Technicians and Physiologists (BTS/ARTP) guidelines
(5) shortly after arrival. All subjects were asked to
avoid consuming alcohol on the day of the visit, to eat
a light breakfast and then to refrain from eating until
after the investigations were completed. The subjects with
lung disease were asked to avoid using any inhaled
medication for at least 4 h before they attended. The
instrument used for spirometry was a Spirobank
Multifunction spirometer (MIR Medical International
Research, Albano Laziale, Rome, Italy) connected to a
laptop computer. Control of the Spirobank spirometer,
data capture and results presentation were via Oce´an
WinSpiro operating software provided by the manufac-
turer. The spirometer calibration was checked prior to
each test run. Spirometry results were recorded as the best
of at least three valid and technically acceptable procedures,
where the results for each parameter were within 5%
tolerance for each individual subject. Reference values
were calculated for each subject from age, height and sex
data using the European Respiratory Society (ERS)
algorithms in accordance with the published ERS 1993
update algorithm set.
BREATH TESTING DEVICE
A Lion Intoxilyzer 6000UK machine was used for breath
alcohol analysis. The device is a micro-processor con-
trolled, multi-filtering infrared spectrometer. The eect of
other alcohols (e.g. methanol, propyl alcohol, isopropyl
alcohol) and ketones (e.g. acetone) in the breath on the
analysis is low and predictable. The device has an enhanced
specificity for ethanol via primary and secondary infrared
wavelengths. If interfering substances are present in the
sample, the test procedure aborts and the message
‘Interfering Substance—Unsatisfactory Specimen 1’ is
displayed and printed. The measurement range for the
Lion Intoxilyzer 6000UK is 0–220 g alcohol 100 ml71 of
breath. The minimum sample volume required by the
device is 12 l, delivered in a continuous manner at a flowgreater than 12 l min71. The mouth pressure required to
generate the minimum continuous flow of 12 l min71
through the breath sampling pathway with non-return
valve mouthpiece attached is 18 mBar.
BREATH TESTING PROCEDURE
The breath testing procedure is preprogrammed into the
Lion Intoxilyzer 6000UK by the manufacturer and cannot
be altered by the operator. The procedure sequence is
identical to that of the previous device—the Lion Intoxi-
meter 3000. Immediately prior to commencement of the test
procedure, the operator is instructed to attach a new
mouthpiece to the device. Single use mouthpieces are
prepacked by the manufacturer. The operator then
proceeds to enter the subject’s surname, forenames, gender
and date of birth via the device’s alpha-numeric operating
keypad. Having verified the details entered, the operator is
then asked to confirm commencement of the breath test
procedure. The device then moves into the analytical test
phase. The remainder of the test cycle runs fully auto-
matically: there is nothing which the subject or operator
can do to influence the course of the analysis. During the
test phase, the instrument progresses through a number of
steps, as detailed below.
Step 1—air blank 1
The instrument purges itself with room air to ensure it is
alcohol-free. Only an air blank reading of 0 g 100 ml71
will allow the test to proceed to the next step. During the
purging and air blank process, air is drawn into the
instrument through the breath tube. By attaching the
mouthpiece prior to this procedure, therefore, this item is
itself checked to ensure and prove that it is contaminant
free and that it is not blocked. If this test does fail, for any
reason, the instrument will abort the procedure and display
an alert message.
Step 2—simulator check 1
A sample of alcohol vapour from a certified gas simulator
cylinder provided by an independent Home Oce supplier
is analysed as a calibration check—again, fully automati-
cally. Only a reading in the range 32–37 g 100 ml71
inclusive is acceptable otherwise the instrument will abort
the procedure.
Step 3—air blank 2
The instrument again purges itself with room air, then tests
itself to ensure it is free of alcohol from the gas standard.
Only a reading of 0 g 100 ml71 will allow the test to
proceed to the next stage.
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The subject has 3 min in which to supply this first specimen.
The manufacturers claim that this 3-min period should
allow up to five attempts. The operator gives the subject the
instructions to take a deep breath, to place the mouthpiece
in his or her mouth and then to exhale continuously
through the mouthpiece to make an audible ‘beeper’ device
sound and to bring up vertical and horizontal bars
indicators on the instrument display. The vertical bar
indicator displays flow rate of breath through the instru-
ment and this must be maintained above a level of 12 l
min71 throughout the breath. The larger horizontal bar
indicator shows the volume of breath (minimum 12 l
required) exhaled into the device and the volume still to be
provided. If the subject has alcohol in his or her breath,
then this horizontal bar indicator will reflect the approach
to alveolar air. As this point approaches, the analyser
monitors the rate of change of breath alcohol and identifies
when a plateau (consistent with alveolar air) occurs. If the
subject has no alcohol in their breath, then the horizontal
display will simply represent the provision of the 12-l
breath requirement as made in such circumstances. The
subject must continue to exhale at a rate above 12 l min71
until the criteria above have been satisfied, the machine has
sounded a double ‘beep’ tone and the message ‘Breath
Specimen Accepted’ has appeared on the instrument
display. At this point the breath sample has been analysed
but no reading is shown at this stage. This is intended to
stop giving perhaps borderline positive subjects a motive
for indulging in some respiratory technique (e.g. hyper-
ventilation prior to blowing) in an attempt to reduce the
breath alcohol level in respect of their second specimen. If
the subject does not blow continuously, or blows and then
stops too early, then the attempt is aborted and the system
purges before inviting the subject to repeat his or her
attempt. If the message ‘Breath Specimen Accepted’ is not
displayed during this step of the procedure, then the subject
has failed the evidential breath test by failing to provide a
specimen of breath.
Step 5—air blank 3
The instrument again purges itself with room air then tests
itself to ensure it is free of alcohol from the first breath
specimen. As in the previous air blank steps, a reading of
0 g 100 ml71 is required to allow the test to proceed.
Step 6—subject’s breath specimen 2
The subject has a further 3 min to supply this second
specimen. This second 3-min period is independent of the
first. The same instructions are given to the subject as for
the first specimen. Again, no result is shown until the end of
the procedure, after the final calibration check. If the
message ‘Breath Specimen Accepted’ is not displayed
during this step of the procedure, then, as in Step 4, the
subject has failed the evidential breath test by failing to
provide a specimen of breath.Step 7—air blank 4
The instrument again purges itself with room air, then tests
itself to ensure it is free of alcohol from the second breath
specimen. Only a reading of 0 g 100 ml71 will allow the
test to proceed to the next stage.
Step 8—simulator check 2 and final purge
A further sample of alcohol vapour from the gas simulator
is now analysed as a final calibration check. Only if this
reading is in the range 32–37 g 100 ml71 inclusive can the
breath test readings already obtained (but yet to be
displayed) be used in evidence. The instrument now purges
the alcohol from its system, so that it is clear until next
required for use.
Step 9—results and printout
The readings are now displayed followed by a printout of
the breath alcohol readings and the two calibration check
results. The printout is generated in a format which allows
it to be signed by the operator and submitted as an
evidential document.
PRE-ALCOHOL BREATH TESTING
Subjects were requested to provide two evidential breath
samples in accordance with the procedure and instructions
described above.
ADMINISTRATION OF ALCOHOL
Those subjects who were able to provide two evidential
breath samples in the pre-alcohol phase were then given a
quantity of vodka (40% vol), depending on body weight,
diluted with an equal volume of fruit juice. The amount of
alcohol required to achieve a breath alcohol level of around
35–45 g 100 ml71 breath was calculated according to body
weight using the following formula, provided by Lion
Laboratories Ltd:
Volume of alcohol 40%vol required ml
 Subject’s weight kg  2162
The physiological reason for diluting the alcohol with an
equal volume of fruit juice is that the rate of absorption of
alcohol in the stomach is greatest at 20% by volume. For
the purposes of the study, this also made the ingestion of
alcohol more palatable. The subjects were asked to
consume the entire quantity of alcohol within 15 min.
POST-ALCOHOL BREATH TESTING
Twenty minutes after completing the ingestion of the
alcohol/fruit juice mixture, the subjects were requested to
provide two further evidential breath samples in accordance
with the procedure and instructions previously described.
TABLE 1. Mean age (SD) and sex of subjects investigated
Subject group Mean age
(years)
Male
(n)
Female
(n)
Control (n=10) 327 (64) 10 0
Asthma (n=10) 583 (128) 9 1
COPD (n=10) 684 (85) 10 0
Restricted (n=10) 525 (119) 3 7
FIG 1. Forced expiratory volume in 1 sec (FEV1) for all
subjects. Asthma (^), COPD (&), restrictive lung disease
(~) and control (x) patients.
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Consumption of alcohol was not a factor in determining
success or failure as all subjects who failed to provide
evidential breath samples failed in the pre-alcohol phase of
the study. The manufacturers state that the 3-min subject
breath specimen periods should allow up to five attempts.
Our study showed that only four attempts were feasible
during each of the two specimen periods, taking into
account the need to instruct subjects properly, to allow
reasonable time for recovery between attempts, and the fact
that patients with COPD in particular may take consider-
ably longer to exhale than others. The details of the subjects
investigated are shown in Table 1. The mean (+SD) results
for spirometry are shown in Table 2. Figure 1 shows the
FEV1 results according to whether or not the subjects were
able to succeed in activating the device. The groups who
succeeded and who did not succeed were compared for each
of the four sub-groups (control, asthma, COPD and
restrictive disease) for the following spirometric parameters:
peak expiratory flow (PEFR); forced expiratory volume in
1 sec (FEV1); forced vital capacity (FVC); forced expiratory
ratio (FER or FEV1/FVC).
In addition, these parameters were also expressed as
percent predicted reference value and potential dierences
analysed between the successful and unsuccessful groups.
Table 3 shows the mean breath alcohol measurements
recorded by the Lion Intoxilyzer 6000UK.
Two asthma subjects, four COPD subjects and three
restricted subjects failed to provide two evidential breath
samples in accordance with the test procedure prescribed by
the manufacturer. Of these subjects, seven out of the nine
had a FEV1 of less than 1 l. Of the nine failures, eight had a
FVC greater than 15 l (range 164–303 l).TABLE 2. Mean spirometric values (SD) of subjects investigated
Subject group Mean FEV1 (l)
Control (n=10) 45 (09)
Asthma (n=10) 15 (07)
COPD (n=10) 10 (03)
Restricted (n=10) 17 (05)Discussion and conclusions
The manufacturers state that a minimum breath sample
volume (i.e. the amount required to be expired regardless of
alcohol content) using the Lion Intoxilyzer 6000UK is
12 l, and a minimum continuous expiratory breath flow
rate of 12 l min71 is required. In patients with lung disease,
maintaining such a minimum flow rate for a period of time
may be problematical given the intrinsic resistance of the
breath sampling pathway (18 mBar at 12 l min71). Twenty-
nine of the 30 subjects with lung disease that we
investigated had a forced vital capacity (FVC) of greater
than 15 l but, nevertheless, eight of them failed to provide
evidential breath samples despite having four attempts
during each of the two sampling periods. The expiratory
breath flow rate fell below the 12 l min71 continuous
threshold required during the breath sampling period for
these subjects. Figure 1 shows that there was some overlap
between the successful and unsuccessful groups regardingMean FER (%) Mean FVC (l)
809 (78) 56 (09)
440 ( 90) 33 (11)
370 (88) 28 (06)
821 (105) 20 (05)
TABLE 3. Mean breath alcohol (SD) of subjects investi-
gated
Subject group Mean breath alcohol
(g 100 ml71)
Control (n=10) 334 (110)
Asthma (n=8) 371 ( 79)
COPD (n=6) 382 (78)
Restricted (n=7) 379 (87)
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function measurements, FEV1 (as indicated in Fig. 1) was
of some predictive value in that subjects who were unable to
provide evidential breath samples were unlikely to have a
FEV1 greater than 1 l. There was, however, still some
overlap even with this parameter in that two subjects with
an FEV1 of less than 10 l were able to provide evidential
breath samples. These two subjects both had restrictive lung
disease. Otherwise there appeared to be no obvious
dierence between the ability to succeed or not to succeed
and the type of underlying lung disease. All of the other
spirometric parameters analysed such as FVC, FER,
PEFR, FEV1% predicted, FVC% predicted, etc. showed
considerably more overlap between the successful and
unsuccessful subjects compared to the FEV1 measurement.
In conclusion, this study has shown that subjects with
lung diseases may have diculty in providing evidential
breath samples using the Lion Intoxilyzer 6000UK as has
been the case with previous evidential devices (1). Most ofthe subjects who were unable to activate the device had a
FEV1 of less than 1 l.
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